This session at the ILTS 2021 Virtual Congress revolved around developing liver transplantation programs. Roberto Hernandez discusses with Prashant Bhangui, Nicolas Goldaracena, and Alfred Kow about the current situations in different countries, the challenges, and the road forward.
Roberto Hernandez-Alejandro is Chief of the Division of Transplantation at the University of Rochester (URMC) since August 2016. There, he’s demonstrated his ability to grow a program, leading his team to double the number of organ transplants with the best outcomes in the program’s history. Under his leadership, URMC restarted live donor liver transplants, performing 30 operations over 2.5 years as well as introducing a very active program of donation after cardiac death. Dr. Hernandez is also heavily focused on liver resections, and is one of a handful of US surgeons performing the ALPPS procedure. Dr. Hernandez recently opened the second active program on liver transplantation for unresectable colorectal liver metastases in the US.
Prashant Bhangui MBBS, MS, Masters in HPB Surgery (Henri Bismuth Institute, France), is a Senior Consultant, Hepatobiliary and Liver Transplant Surgeon at the Medanta Institute of Liver Transplantation and Regenerative Medicine, Medanta-The Medicity, Delhi NCR, India. He was a Chair of the Vanguard Committee and currently a member of the Education and Scholarship Committee and Development Committee of the ILTS. Dr. Bhangui’s areas of research include hepatocellular carcinoma, colorectal liver metastases, and living donor liver transplantation. He has several publications in key peer-reviewed International journals on these subjects and serves on the Reviewer panel of high index factor HPB Surgery and Transplant Journals.
Alfred Kow Wei Chieh
Alfred Kow Wei Chieh is the Assistant Dean (Education) of the Yong Loo Lin School of Medicine at National University of Singapore and a Senior Consultant at the National University Center for Organ Transplantation, National University Health System Singapore. He is also a Senior Consultant at the Department of Surgery at the National University Hospital and a Senior Consultant at the Division of Surgical Oncology at the National University Cancer Institute (NCIS) Singapore.
Nicolás Goldaracena, MD, serves as surgical director of the UVA Living Donor Liver Transplant Program and UVA Pediatric Liver Transplant Program. His clinical practice focuses on living donor hepatectomy, living donor liver transplantation, pediatric liver transplant, and liver cancer and pancreatic surgery. Dr. Goldaracena’s research is focused on clinical outcomes of adult and pediatric liver transplantation. He has a special interest in increasing the donor organ pool and reducing mortality among those on liver transplant waiting lists by advancing living donor liver transplantation.